Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders

6 Nov 2018

Abstract excerpt

Chronic active Epstein-Barr virus infection (CAEBV) is a prototype of EBV-associated T- and/or NK-cell (EBV+ T/NK-cell) lymphoproliferative disorders. Most subtypes of these LPDs are lethal. We established a unified treatment strategy composed of step 1 (immunochemotherapy: steroids, cyclosporine A, and etoposide), step 2 (multi-drug block chemotherapy), and step 3 (allogeneic hematopoietic stem cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Immune Cell Function and Interaction
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30460216
DOI: 10.3389/fped.2018.00334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated DisordersPMID 30460216Read ↗

T cell-Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis (HLH) occurs in Non-Asians and is associated with a T cell activation state that is comparable to primary HLHSemantic proximity Read ↗

Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of DevelopmentSemantic proximity Read ↗

Chronic active EBV infection with hemophagocytic lymphohistiocytosis and progression to aggressive NK cell leukemiaSemantic proximity Read ↗

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disordersSemantic proximity Read ↗

Epstein‐Barr virus post‐transplant lymphoproliferative disease ( PTLD ) after hematopoietic stem cell transplantationSemantic proximity Read ↗

Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatmentSemantic proximity Read ↗

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.Semantic proximity Read ↗

Primary immunodeficiencies predisposed to Epstein‐Barr virus‐driven haematological diseasesSemantic proximity Read ↗

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationSemantic proximity Read ↗

Chronic active EB virus infection with hemophagocytic lymphohistiocytosis and progression to aggressive NK cell leukemia: a case report and review of the literatureSemantic proximity Read ↗

Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.Semantic proximity Read ↗

Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.